Navigation Links
A Functional Immune System Can Be Derived From Embryonic Stem Cells, Preliminary Study Finds
Date:2/12/2008

WASHINGTON, Feb. 12 /PRNewswire-USNewswire/ -- A new study demonstrates for the first time that embryonic stem cells can be used to create functional immune system blood cells, a finding which is an important step in the utilization of embryonic stem cells as an alternative source of cells for bone marrow transplantation. This hopeful news for patients with severe blood and immune disorders, who need these transplants for treatment, was prepublished online in Blood, the official journal of the American Society of Hematology.

Embryonic stem cells (ESCs) are being intensely investigated as a renewable source of primitive cells theoretically able to regenerate all tissues and organs. The use of ESC-derived blood-forming cells may have an important advantage over traditional transplants that use bone marrow, umbilical cord blood, and peripheral blood from donors. The antigens on the surface of donated cells must be compatible (determined by a method called HLA matching) with those of the patient to prevent rejection. The use of embryonic stem cells, which have low levels of these antigens and may therefore be less likely to provoke a defensive reaction by the patient's body, may allow patients who can't find suitable HLA-matched donors to receive transplants.

Previous studies have shown that mouse ESCs can be coaxed to form blood-forming hematopoietic cells by introducing a protein called HOXB4, known for its unique ability to greatly enhance cell proliferation, into them. These cells could then be transplanted into mice whose own marrow had been destroyed by radiation, rescuing their marrow function and beginning to produce necessary blood cells. However, previous studies have not investigated whether ESC-derived bone marrow in these mice could regenerate normal immune function -- in particular, if they could allow the mice to respond to viruses or vaccines. Because fetuses have no need for a functional immune system as they are protected from
'/>"/>

SOURCE American Society of Hematology
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Genetic Immunity Presents Clinical Data on DermaVir Patch Immune Therapy at 15th Annual Conference on Retroviruses and Opportunistic Infections
2. Pixantrone Shows Activity in a Preclinical Study of Experimental Autoimmune Myasthenia Gravis (EAMG)
3. Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
5. Researchers Train the Immune System to Deliver Virus That Destroys Cancer in Lab Models
6. Bristol-Myers Squibb, New Jersey Childrens Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
7. MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
8. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
9. MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
10. MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results
11. Peptimmune Initiates Phase I Study With a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)... -- Biotech scientists increasingly are applying g...ter understand the effects of novel drug candidate...Engineering & Biotechnology News ( GEN ). The...compound,s mechanism of action and eventually deve...g to the November 15 issue of GEN . ( http://www....
(Date:11/18/2008)...l/ -- NeuroDiscovery Ltd (ASX:,NDL), a specialty ... Company,and Sosei Group Corporation ("Sosei"; T...biopharmaceutical company, today announce that Neu...nical efficacy data for NSL-043/SD118.,This inves...thic pain and has,successfully completed Phase I ...
(Date:11/18/2008)...wswire/ -- Forty-two leading U. S. scientists and ...to consider cutting-edge innovations that may defe...om outbreaks of dangerous zoonotic diseases, the F... innovations: , , , , A "Doc in...ts highly contagious and dangerous zoonotic diseas...
(Date:11/13/2008)...FirstCall/ -- Hologic, Inc.,(Nasdaq: HOLX ), a le...ium,diagnostics, medical imaging systems and surgi...eeds of women, today announced the results of the,... Cervista HPV high-risk,test is currently under re...launched in the European Union (EU) early in 2009....
Breaking Medicine Technology:GEN Reports on the Trend Toward Predictive Toxicogenomics 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 3Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 4Bioenvision Shareholders Approve Acquisition by Genzyme Corporation 4322 1Bioenvision Shareholders Approve Acquisition by Genzyme Corporation 4322 2Bioenvision Shareholders Approve Acquisition by Genzyme Corporation 4322 3Bioenvision Shareholders Approve Acquisition by Genzyme Corporation 4322 4Committee to Reduce Infection Deaths Releases 10 Lifesaving Steps to Protect Students from MRSA Infections 4317 1Committee to Reduce Infection Deaths Releases 10 Lifesaving Steps to Protect Students from MRSA Infections 4317 2Abbott Announces Positive One Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 599 1Abbott Announces Positive One Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 599 2Abbott Announces Positive One Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 599 3drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 1drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 2drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 3drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 4drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 5drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 6drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 7drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 8drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 9drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 10drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 11drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 12drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 13drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 14
...NEW YORK--(BUSINESS WIRE)--Apr 12, 2007 - INNOVIVE...d that data from preclinical,studies of INNO-406, ...r for Gleevec-resistant or treatment-intolerant ch...he American Association,for Cancer Research Annual...7 at the Los Angeles Convention Center in Los Ange...
... BRANFORD, Conn., April 12, 2007 /PRNewswire-First...new preclinical data on,belinostat (PXD101), a his...ed for the treatment of cancer, and velafermin, a ...evere oral mucositis,will be presented at the upc...CR) 2007 Annual Meeting in Los Angeles, CA, April,...
Other Medicine Technology:Innovive Pharmaceuticals Announces Additional Data Presentations at,American Association for Cancer Research Annual Meeting 2CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 2CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 3CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 4
(Date:11/21/2008)...for preterm labor , , FRIDAY, Nov. 21 (H...e switch that activates the uterine muscles for co...ad to therapies for preterm labor. , The molec...the surface of these uterine muscle cells, keeping...But researchers from Dartmouth Medical School in N...
(Date:11/21/2008)... State University College of Medicine research tea... new layer of regulation in the cell division cycl...the way cancer begins. , Wang, an assistant prof...icine, said the findings will lead to an improved ...esign of new drugs that kill cancer cells by inhib...
(Date:11/21/2008)...re-FirstCall/ -- Heska Corporation,(Nasdaq: HSK...k Society of,Security Analysts, 12th Annual Biote... 2008 at 1177 Avenue of the Americas, 2nd Floor in...egin at 9:35 a.m. Eastern Time (7:35 a.m.,Mountai... for two weeks,following the presentation through...
(Date:11/21/2008)...out future antibiotic resistance from widespread u...) -- People with moderate to severe chronic obstru...ce the frequency of exacerbations through a regula...ays. , The study, published in the first issue...ory and Critical Care Medicine , found that twice-...
Breaking Medicine News(10 mins):Health News:Long-Term Erythromycin Cut COPD Complications 2
...ed from patients who are in for these tests. Resea...t present which will help spare some couples the c...e Werlin, M.D., and researchers from the Genesis N...olved in a study looking at the benefits of preimp...
... into energy-producing muscle fibres – mocking the...ard Medical School discovered a protein in muscle ...rsity of Texas, they reveal that the protein has t...There are two types of muscle fibre. Type II is th...
...ry did not improve, attention or concentration in ...l extract much prized for many years for its effec...gested it may be helpful in improving memory //in ...ko can increase mental sharpness in those who are ...
...ioxidant treatment improves circulation and reduce... Peripheral artery disease is a narrowing of the a...cts an estimated 5 million to 10 million people in...have no symptoms, one of the major signs of the co...
Other Medicine News:
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: